Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Vivos Therapeutics (VVOS) Debt to Equity (2019 - 2025)

Historic Debt to Equity for Vivos Therapeutics (VVOS) over the last 4 years, with Q3 2025 value amounting to $3.44.

  • Vivos Therapeutics' Debt to Equity changed N/A to $3.44 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.44, marking a year-over-year change of. This contributed to the annual value of $0.05 for FY2021, which is 3504.38% down from last year.
  • Per Vivos Therapeutics' latest filing, its Debt to Equity stood at $3.44 for Q3 2025.
  • Vivos Therapeutics' 5-year Debt to Equity high stood at $3.44 for Q3 2025, and its period low was $0.03 during Q2 2021.